Independent Prognostic Value of Flow Cytometry (FCM) in Myelodysplastic Syndromes (MDS) - Composition of a Prognostic FCM-Score for Overall Survival
Uta Oelschlaegel(University Hospital Carl Gustav Carus), Shahram Kordasti(Guy's Hospital), Martin Bornhäuser(Technische Universität Dresden), Jessica A. Timms(King's College London), Theresia M. Westers(Vrije Universiteit Amsterdam), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Farzin Farzaneh, Susann Winter(University Hospital Carl Gustav Carus), Katja Sockel(Innsbruck Medical University), Uwe Platzbecker(National Center for Tumor Diseases), Mieke Van Hemelrijck(Ghent University Hospital), Arjan van de Loosdrecht(Amsterdam University Medical Centers), Aida Santaolalla(King's College London)
Cited by 1
Related Papers
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
|Blood|2019|655